Similar articles

• Antimicrobial peptides in COPD--basic biology and therapeutic applications.

  Bals R, Hiemstra PS. Bals R, et al. Curr Drug Targets. 2006 Jun;7(6):743-50. doi: 10.2174/138945006777435227. Curr Drug Targets. 2006. PMID: 16787176 Review.
• Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.

  Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Qaseem A, et al. Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008. Ann Intern Med. 2011. PMID: 21810710
• Update on the Pathogenesis of COPD. Reply.

  Agustí A, Hogg JC. Agustí A, et al. N Engl J Med. 2019 Dec 19;381(25):2484. doi: 10.1056/NEJMc1914437. N Engl J Med. 2019. PMID: 31851816 No abstract available.
• Update on the Pathogenesis of COPD.

  Eapen MS, Sohal SS. Eapen MS, et al. N Engl J Med. 2019 Dec 19;381(25):2483-2484. doi: 10.1056/NEJMc1914437. N Engl J Med. 2019. PMID: 31851815 No abstract available.
• Update on the management of COPD.

  Celli BR. Celli BR. Chest. 2008 Jun;133(6):1451-1462. doi: 10.1378/chest.07-2061. Chest. 2008. PMID: 18574288 Review.